Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2018 Sep 16.

Published in final edited form as: Burns. 2006 Jul 11;32(6):755–764. doi: 10.1016/j.burns.2006.01.011

Table 2.

ROI-derived fitted time-activity curve parameters

Experimental group^a	Fitting parameter^b

	A^c	B^d	C^c
0 A saline	538.5	0.0359	53.0
1.85 A saline	251.1	0.0146	239.3
1.85 A 17 mg poloxamer-188	24.0	0.0021	162.5
1.85 A 68 mg poloxamer-188	195.2	0.0193	274.1
1.85 A 17 mg 10-kDa dextran	966.2	0.0781	244.9
1.85 A 17 mg 40 kDa dextran	174.6	0.0151	250.2
0 A 17 mg poloxamer-188	696.7	0.0409	87.0

^a

Designated by applied current and therapeutic agent.

^b

Exponential decay + constant background model: f(t) = A exp(−Bt) + C.

^c

Magnitude; in units of counts in ROI per 2-min image.

^d

Decay constant; in units of min⁻¹.